GlassScriptPhysician profile
Barry H Burkhardt
NPI 1548233083
$1,296.75
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $237 · 2021: $84.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $233.30 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $221.13 | 2019 | |
| Merck Sharp & Dohme LLC | $192.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $167.45 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $61.27 | 2019-2020 | |
| Amarin Pharma, INC. | $60.08 | 2019-2020 | |
| Astellas Pharma US INC | $50.09 | 2019-2020 | |
| Amgen INC. | $49.64 | 2019-2020 | |
| Novo Nordisk INC | $46.66 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.17 | 2019-2021 | |
| Phadia US INC. | $38.69 | 2019 | |
| Sanofi Pasteur INC. | $38.49 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $24.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.76 | 2019 | |
| Ibsa Pharma INC. | $17.42 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $17.32 | 2019 | |
| Allergan, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Burkhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.